Survival impact on regorafenib (REG) and trifluridine/tipiracil hydrochloride (FTD/TPI) for patients with metastatic colorectal cancer: Single institutional experience.-MedSci.cn

Survival impact on regorafenib (REG) and trifluridine/tipiracil hydrochloride (FTD/TPI) for patients with metastatic colorectal cancer: Single institutional experience.

Chida, K; Kotani, D; Sawada, K; Nakamura, Y; Kawazoe, A; Kuboki, Y; Shitara, K; Kojima, T; Taniguchi, H; Yoshino, T

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (4):

科室
- - 订阅+
  - 更多科室
工具
服务